ID   EPFLi004-A
SY   hiPS2; ips2; iPS clone 2
DR   BioSamples; SAMEA104012166
DR   EBiSC; EPFLi004-A
DR   ECACC; 66540576
DR   GEO; GSM1395301
DR   hPSCreg; EPFLi004-A
DR   Wikidata; Q54832359
RX   PubMed=24879558;
CC   From: Ecole Polytechnique Federale de Lausanne; Lausanne; Switzerland.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Discontinued: EBiSC; EPFLi004-A; true.
CC   Discontinued: ECACC; 66540576; true.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD34 ! EPFLi001-A
OI   CVCL_VD35 ! EPFLi002-A
OI   CVCL_VD36 ! EPFLi003-A
OI   CVCL_VD38 ! EPFLi005-A
OI   CVCL_VD39 ! EPFLi006-A
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 7
RX   PubMed=24879558; DOI=10.1101/gr.172809.114;
RA   Friedli M., Turelli P., Kapopoulou A., Rauwel B., Castro-Diaz N.,
RA   Rowe H.M., Ecco G., Unzu C., Planet E., Lombardo A., Mangeat B.,
RA   Wildhaber B.E., Naldini L., Trono D.;
RT   "Loss of transcriptional control over endogenous retroelements during
RT   reprogramming to pluripotency.";
RL   Genome Res. 24:1251-1259(2014).